GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » ROA %

Universal Ibogaine (TSXV:IBO) ROA % : -15.96% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Universal Ibogaine's annualized Net Income for the quarter that ended in Jan. 2024 was C$-0.89 Mil. Universal Ibogaine's average Total Assets over the quarter that ended in Jan. 2024 was C$5.56 Mil. Therefore, Universal Ibogaine's annualized ROA % for the quarter that ended in Jan. 2024 was -15.96%.

The historical rank and industry rank for Universal Ibogaine's ROA % or its related term are showing as below:

TSXV:IBO' s ROA % Range Over the Past 10 Years
Min: -246.47   Med: -55.55   Max: -20.8
Current: -20.8

During the past 7 years, Universal Ibogaine's highest ROA % was -20.80%. The lowest was -246.47%. And the median was -55.55%.

TSXV:IBO's ROA % is ranked better than
63.94% of 1550 companies
in the Biotechnology industry
Industry Median: -34.765 vs TSXV:IBO: -20.80

Universal Ibogaine ROA % Historical Data

The historical data trend for Universal Ibogaine's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine ROA % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
ROA %
Get a 7-Day Free Trial -36.43 -70.66 -25.13 -246.47 -40.44

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -51.83 -32.80 -18.92 -15.10 -15.96

Competitive Comparison of Universal Ibogaine's ROA %

For the Biotechnology subindustry, Universal Ibogaine's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's ROA % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's ROA % falls into.



Universal Ibogaine ROA % Calculation

Universal Ibogaine's annualized ROA % for the fiscal year that ended in Jul. 2023 is calculated as:

ROA %=Net Income (A: Jul. 2023 )/( (Total Assets (A: Jul. 2022 )+Total Assets (A: Jul. 2023 ))/ count )
=-2.39/( (6.318+5.502)/ 2 )
=-2.39/5.91
=-40.44 %

Universal Ibogaine's annualized ROA % for the quarter that ended in Jan. 2024 is calculated as:

ROA %=Net Income (Q: Jan. 2024 )/( (Total Assets (Q: Oct. 2023 )+Total Assets (Q: Jan. 2024 ))/ count )
=-0.888/( (5.52+5.607)/ 2 )
=-0.888/5.5635
=-15.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jan. 2024) net income data. ROA % is displayed in the 30-year financial page.


Universal Ibogaine  (TSXV:IBO) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jan. 2024 )
=Net Income/Total Assets
=-0.888/5.5635
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.888 / 2.356)*(2.356 / 5.5635)
=Net Margin %*Asset Turnover
=-37.69 %*0.4235
=-15.96 %

Note: The Net Income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Universal Ibogaine ROA % Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines